Show Summary Details
Page of

Mesothelioma and chest wall pain 

Mesothelioma and chest wall pain
Mesothelioma and chest wall pain

Manohar Sharma

and Sanjeeva Gupta

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 September 2021

Approximately 1800 new cases of mesothelioma are diagnosed each year in England. Most people who develop mesothelioma have worked in jobs where they inhaled asbestos, or were exposed to asbestos dust and fibres in other ways. The large majority of patients will die within a year of diagnosis. Mesothelioma incidence is still rising and is expected to peak between 2010 and 2015. Between 2006 and 2020 up to 30,000 people will die of the disease in the UK. Patients with mesothelioma frequently suffer distressing symptoms including breathlessness, chest pain, fatigue, and weight loss. Intractable pain in particular is a key issue. Pain is caused by tumour compressing on the remaining lung, pleural effusion, infiltration of tumour into chest wall and neural structures. Often the pain can be as a result of surgery to resect the tumour or take biopsy. Pain can be often controlled with simple analgesic and strong opioids in line with the World Health Organization analgesic ladder. However, in a number of cases pain is refractory and severe. In these cases pain management options including nerve blocks, intrathecal neurolysis, spinal infusions, and cordotomy must be accessible and considered early.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.